APMC
TYRA icon

Alta Partners Management Company’s Tyra Biosciences TYRA Stock Holding History

Alta Partners Management Company’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122M Hold
3,823,425
– – 95.92% 1
2026
Q1 		$146M Hold
3,823,425
– – 96.97% 1
2025
Q4 		$101M Sell
3,823,425
-256,871
-6% -$4.72M 97.03% 1
2025
Q3 		$57.1M Hold
4,080,296
– – 95.15% 1
2025
Q2 		$39M Hold
4,080,296
– – 93.82% 1
2025
Q1 		$37.9M Hold
4,080,296
– – 90.83% 1
2024
Q4 		$56.7M Buy
+4,080,296
New +$74M 89.47% 1

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Alta Partners Management Company's TYRA Position: Q2 2026 in Review

Alta Partners Management Company held its Tyra Biosciences (TYRA) position steady in Q2 2026 at 3,823,425 shares worth $122M. The position accounts for 95.92% of the portfolio, ranked #1.

Alta Partners Management Company first reported a position in TYRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $146M in Q1 2026. 170 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Alta Partners Management Company held 3,823,425 shares of Tyra Biosciences worth $122M as of Q2 2026.
  • Alta Partners Management Company left its Tyra Biosciences share count unchanged in Q2 2026.
  • Tyra Biosciences made up 95.92% of Alta Partners Management Company's portfolio in Q2 2026, its #1 holding.
  • Alta Partners Management Company first reported a position in Tyra Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Alta Partners Management Company's Tyra Biosciences position peaked at $146M in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Alta Partners Management Company's 13F filing for Q2 2026, filed 22 Jul 2026.